DURHAM, North Carolina, June 05, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea cède ses activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
DURHAM, Caroline du Nord, 05 juin 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea stellt umfassende Lösung zur Verbesserung von Diversität und Inklusion in der klinischen Forschung vor
DURHAM, North Carolina, May 31, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea lance une solution complète pour améliorer la diversité et l’inclusion dans la recherche clinique
DURHAM, État de Caroline du Nord, 31 mai 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Apresenta Solução Abrangente para Aprimorar a Diversidade e Inclusão na Pesquisa Clínica
DURHAM, N.C., May 31, 2024 (GLOBE NEWSWIRE) — A Read more »
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) — Read more »
Curia e Carterra Fazem Parceria em Simpósio para o Avanço da Pesquisa Biotecnológica do Noroeste do Pacífico
ALBANY, N.Y. e SALT LAKE CITY, May 10, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, e a Carterra Inc., líder [...] Read more »
Curia und Carterra kooperieren bei Biologika-Symposium zur Förderung der Biotechnologieforschung im pazifischen Nordwesten
ALBANY, New York und SALT LAKE CITY, May 10, 2024 (GLOBE NEWSWIRE) — Curia, ein führendes Auftragsforschungsinstitut sowie Entwicklungs– und Produktionsunternehmen, und Carterra Inc., der Weltmarktführer im Bereich [...] Read more »
Curia et Carterra coorganisent un symposium sur les produits biologiques pour encourager la recherche en biotechnologie dans le nord-ouest du Pacifique
ALBANY, New York et SALT LAKE CITY, 10 mai 2024 (GLOBE NEWSWIRE) — Curia, une organisation de premier plan du domaine de la recherche, du développement et de la fabrication sous contrat, et Carterra Inc., leader mondial de la [...] Read more »
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
ALBANY, N.Y. and SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the world leader in label–free high throughput [...] Read more »
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors
Read more »
Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases
TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar [...] Read more »
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician–researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star [...] Read more »
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) — The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most [...] Read more »